IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Associates IX, LLC

Q3 2019 Holdings

Filed 2019-11-12 | 7 holdings | $60.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Intellia Therapeutics Inc(NTLA)COM45826J105$21.6K1,615,32135.5%
Spero Therapeutics Inc(SPRO)COM84833T103$14.6K1,376,96824.0%
Surface Oncology IncCOM86877M209$6.6K4,645,45310.9%
Synlogic IncCOM87166L100$6.1K2,651,96310.0%
Unum Therapeutics IncCOM903214104$4.8K3,361,5358.0%
Carbon Black IncCOM14081R103$4.7K181,2737.8%
Snap Inc(SNAP)CL A83304A106$2.4K150,1603.9%